Overview
Thyroxine Replacement in Organ Donors
Status:
Completed
Completed
Trial end date:
2010-10-01
2010-10-01
Target enrollment:
0
0
Participant gender:
All
All
Summary
To compare oral versus intravenous administration of thyroid hormone: 1) for reversibility of hemodynamic instability in organ donors, and, 2) the pharmacokinetics of oral vs iv thyroid administrationPhase:
Phase 1/Phase 2Accepts Healthy Volunteers?
Accepts Healthy VolunteersDetails
Lead Sponsor:
Lawson Health Research Institute
Criteria
Inclusion Criteria:1. Brain death criteria established
2. Consent for organ donation received
Exclusion Criteria:
1. immediate (< 4 Hrs) organ retrieval anticipated